Registry for studying hypertension types and treatment in Morocco
Hypertension Registry: Study of Primary and Secondary Hypertension Phenotypes, Complications, and Treatment Personalization.
This study is collecting health information from adults with high blood pressure in Morocco to see how different types of hypertension are treated and to improve care for patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Moroccan Society of Cardiology Academic / other |
| Locations | 5 sites (Meknes, Morocco and 4 other locations) |
| Trial ID | NCT06769269 on ClinicalTrials.gov |
What this trial studies
This observational study focuses on collecting medical data related to primary and secondary hypertension in Morocco through an electronic registry. It aims to standardize blood pressure measurements and gather comprehensive clinical, therapeutic, and complication data from patients aged 18 and over with confirmed hypertension. Investigators will be trained to ensure accuracy, and patient data will be transmitted anonymously via a secure channel. The study seeks to improve the quality of primary healthcare for hypertension management in the region.
Who should consider this trial
Good fit: Ideal candidates include individuals aged 18 and over with a confirmed diagnosis of hypertension.
Not a fit: Patients under 18 years old or those without a diagnosis of hypertension will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance the personalization of hypertension treatment and improve patient outcomes in Morocco.
How similar studies have performed: While there may be similar observational studies, this specific approach focusing on hypertension in Morocco is novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals aged over 18 years. * Patients with blood pressure: * Higher than 140 mmHg systolic and/or higher or equal to 90 mmHg diastolic in consultation or in a hospital setting. * Higher than 135/85 mmHg at home or in ambulatory blood pressure measurements (ABPM). * Patients who have agreed and signed the informed consent. * Patients with legal status in the Moroccan kingdom. Exclusion Criteria: * Patient without diagnosis of hypertension * Patient under 18 years old * Patients refusing to sign the informed consent. * Patients with illegal status in the kingdom.
Where this trial is running
Meknes, Morocco and 4 other locations
- Moroccan Society of Cardiology — Meknes, Morocco, Morocco (Recruiting)
- Moroccan Society of Cardiology — Casablanca, Morocco (Recruiting)
- Um6ssp — Casablanca, Morocco (Recruiting)
- Ibn Sina Hospital Center — Rabat, Morocco (Recruiting)
- Mohamed V Military Hospital — Rabat, Morocco (Recruiting)
Study contacts
- Study coordinator: F&C Clinical Trials
- Email: infos@fc-ct.com
- Phone: +33 7 69 27 88 10
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.